The GDP Non-Compliance Reports of 2021 - An Overview

Wholesale trade in medicinal products requires a wholesale authorisation. A certificate of Good Distribution Practice (GDP) is issued to a wholesale distributor by the national competent authority.

If the outcome of an inspection is that the wholesale Distributor does not comply with Good Distribution Practice, a statement of non-compliance may be entered into EudraGMDP. The EudraGMDP database is maintained and operated by the EMA.

Number of Reports

The number of GDP non-compliance reports entered into the EudraGMDP database in 2021 is – like the total number of reports – quite low. The following table gives an overview of the number of reports in recent years:

Year Number of GDP non-compliance reports
2021 6
2020 6
2019 6
2018 4
2017 1
2016 1
2015 0
2014 1
Total 25

Evaluation of the Reports entered in 2021

In 2021, the following reports were entered into the database (by clicking on the report number, you will get to a summary of the respective report):

Report Number Issue Date Country 2021-12-03 Germany
G3-6300.GH_Rowi-Med_20210816 2021-10-01 Germany
sukls162731/2021 2021-08-06 Czechia
NCD/011/RO 2021-04-15 Romania
1 2021-03-05 Germany
NCD/010/RO 2021-01-22 Romania

The following table gives an overview of the deficiencies that led to issuing of the GDP non-compliance reports entered in 2021. The total number of deficiencies is greater than the number of reports, as in some cases several topics were listed:

Area Details Quantity
Responsible Person (RP)

Doubtful reliability / No responsible person who possesses the required expert knowledge / RP does not properly perform his or her duties

Premises / storage

No suitable and adequate premises or storage areas, installations and facilities / Storage of expired medicinal products in between those ready for trading / Storage of expired medicinal products in regular stock

Procurement Procuring from entities which are not authorized for wholesaling activities / Trading of medicinal products with unclear trade chain 2
Quality system No GDP conform quality system 1
Change Management

No change control system



Deviations were not documented

Self-Inspections No self-inspections were performed 1
Training Information on staff training could not be provided 1
Counterfeit medicines Trading of falsified medicinal products


CEO Doubtful reliability


Others Missing connection to the securepharm-system /
Company changed its address without information to or inspection of the competent authority

Go back


Stay informed with the GMP Newsletters from ECA

GMP Newsletter

The ECA offers various free of charge GMP newsletters for which you can subscribe to according to your needs.

To subscribe, please click here.